Detalhe da pesquisa
1.
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia.
N Engl J Med;
389(15): 1390-1401, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37754204
2.
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Clin Infect Dis;
78(2): 259-268, 2024 02 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37740559
3.
External Validation of the 2023 Duke-International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis.
Clin Infect Dis;
78(4): 922-929, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38330166
4.
Exploration of a Potential DOOR Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs.
Clin Infect Dis;
2024 Mar 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38527855
5.
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study.
Clin Infect Dis;
78(3): 775-784, 2024 03 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37815489
6.
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
N Engl J Med;
384(10): 905-914, 2021 03 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33356051
7.
Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection.
J Antimicrob Chemother;
79(6): 1456-1461, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38708907
8.
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Clin Infect Dis;
76(3): e1157-e1165, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36031403
9.
Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs.
Clin Infect Dis;
77(4): 649-656, 2023 08 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37073571
10.
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
Clin Infect Dis;
77(Suppl 4): S295-S304, 2023 10 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37843115
11.
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Ann Intern Med;
175(2): 234-243, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34928698
12.
Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management.
Clin Infect Dis;
75(9): 1668-1674, 2022 10 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35535790
13.
Antiplatelet Therapy in Staphylococcus aureus Bacteremia: No Time Like the Past?
Antimicrob Agents Chemother;
66(6): e0036522, 2022 06 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35535570
14.
Determination of plasma protein binding of dalbavancin.
J Antimicrob Chemother;
77(7): 1899-1902, 2022 06 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35488862
15.
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Crit Care;
26(1): 355, 2022 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36380312
16.
Patients' Experiences With Staphylococcus aureus and Gram-negative Bacterial Bloodstream Infections: A Qualitative Descriptive Study and Concept Elicitation Phase To Inform Measurement of Patient-reported Quality of Life.
Clin Infect Dis;
73(2): 237-247, 2021 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32445467
17.
Antibacterial Resistance Leadership Group 2.0: Back to Business.
Clin Infect Dis;
73(4): 730-739, 2021 08 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33588438
18.
Ceftobiprole for Staphylococcus aureus Bacteremia. Reply.
N Engl J Med;
389(26): 2498-2499, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38157515
19.
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE).
Clin Infect Dis;
70(8): 1536-1545, 2020 04 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31157370
20.
Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen.
Antimicrob Agents Chemother;
64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32393495